April 2023 - Page 5 of 6 - NetworkNewsWire

TuesdayApr 11, 2023 9:00 am

Reflex Advanced Materials Corp. (CSE: RFLX) (OTCQB: RFLXF) Is ‘One to Watch’

Reflex Advanced Materials has begun the qualification process and boasts established relationships with more than 25 key North American customers, putting it years ahead of the competition in the lengthy graphite sales cycle. The company has a planned summer 2023 drill program at the Ruby Graphite project in Montana. Reflex Advanced Materials has entered a metallurgical partnership with AETC to create a technical data sheet on Ruby Graphite material. The company has executed two critical product development and material research partnerships in an effort to diversify risk and improve margins. The U.S. Department of Energy is in the process of…

MondayApr 10, 2023 11:15 am

Coyuchi Inc.’s Organic Bedding Collection Combines Coastal-Inspired Landscape Themes with Sustainable Cotton Material

Coyuchi's line of gold-standard luxury home goods includes bedding, sheets, towels, apparel, and other home goods made using 100% organic cotton The organic bedding market was valued at $836.4 million in 2020, and is expected to grow at a CAGR of 5.1%, resulting in a value of $1.1 billion by 2025 Coyuchi’s Bedroom Inspiration is uniquely designed to calm, revitalize, and build a mindfully made mood within an end user’s personal organic sleeping space At the forefront of consumer organic home products is Coyuchi, a gold standard in sustainable luxury home goods, including bedding, sheets, towels, apparel, and other home…

MondayApr 10, 2023 10:30 am

Cybersecurity Expertise Provider SideChannel Inc. (SDCH) Teams with Risk Data Platform Developer Darkbeam

Massachusetts-headquartered cybersecurity services and technology provider SideChannel Inc. has dedicated itself to serving SMB companies who may be unable to employ on-staff cyber risk management personnel, delivering expertise on contract instead SideChannel recently bolstered its “virtual” chief information security officer (“vCISO”) service by partnering with automated supply chain risk management platform developer Darkbeam, a London-based company similarly focused on client cyber security Darkbeam’s platform provides tools for clients to do data dives on affiliated domains and monitor changes in their security status by analyzing a “Cyber Intelligence Quotient” SideChannel also offers clients a microsegmentation tool as a software-as-a-service (“SaaS”) subscription…

MondayApr 10, 2023 9:45 am

D-Wave Quantum Inc. (NYSE: QBTS) Provides Practical Quantum Computing Solutions to Help Companies Improve Operational Efficiencies and Navigate Complexity

D-Wave has worked on quantum hybrid applications with commercial customers including industry leaders like Volkswagen, Mastercard, Deloitte, ArcelorMittal, Siemens Healthineers, Unisys, Accenture, BBVA, NEC Corporation, Pattison Food Group Ltd., DENSO, and Lockheed Martin The company’s intellectual property portfolio includes more than 210 issued US patents and more than 100 peer-reviewed papers in leading scientific journals D-Wave’s customer success stories showcase the company’s quantum computing technology in action D-Wave Quantum (NYSE: QBTS), a leader in quantum computing systems, software and services, focused on delivering value to customers via practical quantum applications for problems such as logistics, artificial intelligence, materials sciences, drug…

MondayApr 10, 2023 9:00 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Revolutionizing Drug Delivery Potential for Active Pharmaceutical Ingredients Using Patented DehydraTECH(TM) Technology

DehydraTECH(TM)-enabled drugs and product formats improve the speed of onset, increase bioavailability, increase brain absorption, enhance drug potency, reduce drug administration costs, and mask unwanted tastes, shown effective with a growing number of medical applications Current DehydraTECH studies (animal and human) include hypertension, dementia, oral nicotine, epilepsy, and diabetes Most recently, Lexaria’s DehydraTECH-CBD studies for hypertension have produced positive results, and the company is seeking IND status with the FDA Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms, has developed a disruptive drug delivery technology with multiple opportunities for success in cannabinoids, oral nicotine and other active…

ThursdayApr 06, 2023 9:45 am

Eloro Resources Ltd. (TSX.V: ELO) (OTCQX: ELRRF) (FSE: P2QM) Releases Promising Update on Iska Iska Project at Metals Investor Forum

Eloro Resources released updates on Iska Iska project at Metals Investor Forum held in Toronto on March 3-4, 2023 Iska Iska is a major silver-tin polymetallic porphyry-epithermal complex located in southern Bolivia Drilling revealed significant breccia pipe containing extensive silver polymetallic mineralization and a high-grade gold-bismuth zone in the underground workings Eloro recently acquired Mina Casiterita and Mina Hoyada properties, geological mapping, sampling, and geophysical surveys in progress, drilling planned in Q1-2023 Dr. Bill Pearson, Executive Vice President of Exploration for Eloro Resources (TSX.V: ELO) (OTCQX: ELRRF) (FSE: P2QM) recently revealed promising drilling results from the company’s Iska Iska project…

ThursdayApr 06, 2023 9:00 am

McEwen Mining Inc.’s (NYSE: MUX) (TSX: MUX) McEwen Copper Advancing Los Azules Project amid Copper Supply Bottlenecks and Growing Demand

McEwen Mining is an asset-rich diversified gold and silver producer in the Americas with significant exposure to copper through its 51.9%-owned McEwen Copper McEwen Copper holds 100% interest in the Los Azules Project in Argentina, which has been shown to have many attributes comparable to world-class copper-gold deposits in South America The subsidiary is advancing the Los Azules Project and has been undertaking infill and step-out exploration drilling McEwen Copper’s focus comes at a time when the world is staring at copper deficits driven by constrained supply amid political instability in top copper-producing countries and increased demand Copper, a base…

WednesdayApr 05, 2023 10:30 am

DGE’s 2nd Diversity in Clinical Trials Summit: Revolutionizing Trial Outcomes through Improved Diversity Outreach and Representation

Chief Medical Officers, Clinical Research Executives, and Patient Advocacy Experts: attend DGE's 2nd Diversity in Clinical Trials Summit, taking place May 10-11 in Philadelphia, PA. Join this unique in-person learning and networking experience aimed to remove obstacles in health equity and provide actionable strategies to increase diverse representation in clinical trials. DGE is bringing together industry-leading experts from global clinical development to discuss the most critical challenges barriers, and methods on how to overcome barriers in order to reduce disparities and achieve health equity. The agenda focuses on increasing representation of underrepresented communities in clinical trials, improving collaborations with patient…

WednesdayApr 05, 2023 9:45 am

Sustain SoCal presents The Future of Housing in CA: Building Sustainable Communities

Housing industry and government leaders, specialist delegates, and property experts, are all invited to attend the Future of Housing event taking place on April 25, 2023. Hosted by Sustain SoCal at UCI-Beal Applied Innovation, Irvine, this insightful event will bring the housing community together to nurture best practices and explore ideas. The Future of Housing event is an assorted continuum of housing stakeholders that collaborate and convene through advocacy, dialogue, education, and research, to develop equitable solutions that serve our common interest. The Future of Housing event strives to deliver solutions that address California’s pressing housing priorities. Attendees can take…

WednesdayApr 05, 2023 9:00 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Targeting Multiple Commercial Applications for Its Patented DehydraTECH(TM) Technology Platform

Lexaria Bioscience, a global innovator in drug delivery platforms, has developed and patented the DehydraTECH(TM) drug delivery platform technology The company has undertaken multiple studies as part of its extensive R&D program involving DehydraTECH, which continues to yield positive results This R&D program is focused on the development of product candidates across four main segments, which represent the platform’s potential commercial applications These segments include the development of DehydraTECH-processed cannabidiol (“CBD”) for hypertension, epilepsy, diabetes and dementia; DehydraTECH-processed oral nicotine; other pharmaceutical areas exploring a wide range of DehydraTECH-processed active molecules; and hemp-derived CBD applications for consumer packaged goods (“CPG”)…

Financial news and publishing for public and private companies

Contact us: 512.354.7000

Month: April 2023